BridgeBio Pharma, Inc. (BBIO)
63.30
-2.45
(-3.73%)
USD |
NASDAQ |
Oct 13, 16:00
63.30
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Total Return Price : 63.30 for Oct. 13, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 13, 2026 | 63.30 |
| October 12, 2026 | 65.75 |
| October 09, 2026 | 65.35 |
| October 08, 2026 | 65.04 |
| October 07, 2026 | 66.50 |
| October 06, 2026 | 66.96 |
| October 05, 2026 | 66.14 |
| October 02, 2026 | 67.25 |
| October 01, 2026 | 66.91 |
| September 30, 2026 | 65.80 |
| September 29, 2026 | 65.97 |
| September 28, 2026 | 66.61 |
| September 25, 2026 | 65.57 |
| September 24, 2026 | 66.28 |
| September 23, 2026 | 65.71 |
| September 22, 2026 | 69.23 |
| September 21, 2026 | 66.58 |
| September 18, 2026 | 66.61 |
| September 17, 2026 | 67.31 |
| September 16, 2026 | 68.30 |
| September 15, 2026 | 68.39 |
| September 14, 2026 | 72.38 |
| September 11, 2026 | 72.44 |
| September 10, 2026 | 72.50 |
| September 09, 2026 | 76.08 |
| Date | Value |
|---|---|
| September 08, 2026 | 74.76 |
| September 04, 2026 | 74.84 |
| September 03, 2026 | 75.41 |
| September 02, 2026 | 76.50 |
| September 01, 2026 | 76.57 |
| August 31, 2026 | 76.59 |
| August 28, 2026 | 76.60 |
| August 27, 2026 | 78.68 |
| August 26, 2026 | 79.37 |
| August 25, 2026 | 80.40 |
| August 24, 2026 | 81.07 |
| August 21, 2026 | 81.50 |
| August 20, 2026 | 82.94 |
| August 19, 2026 | 83.95 |
| August 18, 2026 | 82.98 |
| August 17, 2026 | 79.89 |
| August 14, 2026 | 79.86 |
| August 13, 2026 | 81.21 |
| August 12, 2026 | 83.84 |
| August 11, 2026 | 83.70 |
| August 10, 2026 | 84.67 |
| August 07, 2026 | 84.48 |
| August 06, 2026 | 82.80 |
| August 05, 2026 | 81.99 |
| August 04, 2026 | 82.07 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 223.82 |
| Pfizer Inc. | 28.37 |
| Ionis Pharmaceuticals, Inc. | 42.38 |
| BioMarin Pharmaceutical, Inc. | 54.38 |
| Vertex Pharmaceuticals, Inc. | 485.22 |